Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karsten Schulmann

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
International Journal of Colorectal Disease|September 4, 2009
Truncating mutations in Peutz-Jeghers syndrome are associated with more polyps, surgical interventions and cancersHeidi Salloch, Anke Reinacher-Schick, Karsten Schulmann, et al.
BMC Cancer|August 11, 2012
Effect of KRAS codon13 mutations in patients with advanced colorectal cancer (advanced CRC) under oxaliplatin containing chemotherapy. Results from a translational study of the AIO colorectal study groupAnke Reinacher-Schick, Karsten Schulmann, Dominik P Modest, et al.
Journal of Cancer Research and Clinical Oncology|March 6, 2021
Microsatellite instability (MSI-H) is associated with a high immunoscore but not with PD-L1 expression or increased survival in patients (pts.) with metastatic colorectal cancer (mCRC) treated with oxaliplatin (ox) and fluoropyrimidine (FP) with and without bevacizumab (bev): a pooled analysis of the AIO KRK 0207 and RO91 trialsStefanie Noepel-Duennebacke, Hendrik Juette, Karsten Schulmann, et al.
Journal of Medical Genetics|June 30, 2011
Biallelic MLH1 SNP cDNA expression or constitutional promoter methylation can hide genomic rearrangements causing Lynch syndromeMonika Morak, Udo Koehler, Hans Konrad Schackert, et al.
Cancer Research|November 3, 2004
Activin type II receptor restoration in ACVR2-deficient colon cancer cells induces transforming growth factor-beta response pathway genesElena Deacu, Yuriko Mori, Fumiaki Sato, et al.
Human Mutation|February 20, 2004
Eight novel MSH6 germline mutations in patients with familial and nonfamilial colorectal cancer selected by loss of protein expression in tumor tissueJens Plaschke, Stefan Krüger, Wolfgang Dietmaier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2004
Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis Colorectal Cancer ConsortiumJens Plaschke, Christoph Engel, Stefan Krüger, et al.
Oncology|July 14, 2006
Mutational and LOH analyses of the chromosome 4q region in esophageal adenocarcinomaAnca Sterian, Takatsugu Kan, Agnes T Berki, et al.
Human Genetics|July 24, 2002
Juvenile polyposis: massive gastric polyposis is more common in MADH4 mutation carriers than in BMPR1A mutation carriersWaltraut Friedl, Siegfried Uhlhaas, Karsten Schulmann, et al.
European Journal of Human Genetics : EJHG|February 28, 2008
Further evidence for heritability of an epimutation in one of 12 cases with MLH1 promoter methylation in blood cells clinically displaying HNPCCMonika Morak, Hans Konrad Schackert, Nils Rahner, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
International Journal of Colorectal Disease|September 4, 2009
Truncating mutations in Peutz-Jeghers syndrome are associated with more polyps, surgical interventions and cancersHeidi Salloch, Anke Reinacher-Schick, Karsten Schulmann, et al.
BMC Cancer|August 11, 2012
Effect of KRAS codon13 mutations in patients with advanced colorectal cancer (advanced CRC) under oxaliplatin containing chemotherapy. Results from a translational study of the AIO colorectal study groupAnke Reinacher-Schick, Karsten Schulmann, Dominik P Modest, et al.
Journal of Cancer Research and Clinical Oncology|March 6, 2021
Microsatellite instability (MSI-H) is associated with a high immunoscore but not with PD-L1 expression or increased survival in patients (pts.) with metastatic colorectal cancer (mCRC) treated with oxaliplatin (ox) and fluoropyrimidine (FP) with and without bevacizumab (bev): a pooled analysis of the AIO KRK 0207 and RO91 trialsStefanie Noepel-Duennebacke, Hendrik Juette, Karsten Schulmann, et al.
Journal of Medical Genetics|June 30, 2011
Biallelic MLH1 SNP cDNA expression or constitutional promoter methylation can hide genomic rearrangements causing Lynch syndromeMonika Morak, Udo Koehler, Hans Konrad Schackert, et al.
Cancer Research|November 3, 2004
Activin type II receptor restoration in ACVR2-deficient colon cancer cells induces transforming growth factor-beta response pathway genesElena Deacu, Yuriko Mori, Fumiaki Sato, et al.
Human Mutation|February 20, 2004
Eight novel MSH6 germline mutations in patients with familial and nonfamilial colorectal cancer selected by loss of protein expression in tumor tissueJens Plaschke, Stefan Krüger, Wolfgang Dietmaier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2004
Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis Colorectal Cancer ConsortiumJens Plaschke, Christoph Engel, Stefan Krüger, et al.
Oncology|July 14, 2006
Mutational and LOH analyses of the chromosome 4q region in esophageal adenocarcinomaAnca Sterian, Takatsugu Kan, Agnes T Berki, et al.
Human Genetics|July 24, 2002
Juvenile polyposis: massive gastric polyposis is more common in MADH4 mutation carriers than in BMPR1A mutation carriersWaltraut Friedl, Siegfried Uhlhaas, Karsten Schulmann, et al.
European Journal of Human Genetics : EJHG|February 28, 2008
Further evidence for heritability of an epimutation in one of 12 cases with MLH1 promoter methylation in blood cells clinically displaying HNPCCMonika Morak, Hans Konrad Schackert, Nils Rahner, et al.
Pageof 5